Does TRACON Pharmaceuticals Inc (NASDAQ:TCON) warrant a purchase right now? What to Consider Before Making a Decision
TRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded -12.45% lower at $0.17 on Wall Street last session. TCON stock price is now -37.43% away from the 50-day moving average and -28.07% away from the 200-day moving average. The market capitalization of the company currently stands at $7.65M. With the price target maintained at $14, BTIG Research recently […]
Does TRACON Pharmaceuticals Inc (NASDAQ:TCON) warrant a purchase right now? What to Consider Before Making a Decision
TRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded 19.50% higher at $0.26 on Wall Street last session. TCON stock price is now -1.10% away from the 50-day moving average and 10.58% away from the 200-day moving average. The market capitalization of the company currently stands at $11.93M. With the price target maintained at $14, BTIG Research recently […]
Despite TRACON Pharmaceuticals Inc [TCON]’s great opportunity, the stock is a bit overvalued
In yesterday’s Wall Street session, TRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded at $0.39, up 7.86% from the previous session. TCON stock price is now 82.68% away from the 50-day moving average and 57.73% away from the 200-day moving average. The market capitalization of the company currently stands at $17.72M. With the price target maintained at […]
There is little time left for TRACON Pharmaceuticals Inc (TCON) to reach its 1-year target estimate. How soon will it surpass it?
TRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded 25.07% higher at $0.22 on Wall Street last session. In accordance with the data, 3 analysts cover TRACON Pharmaceuticals Inc (NASDAQ:TCON). The consensus rating among analysts is ‘Overweight’. TCON stock price is now 20.19% away from the 50-day moving average and -69.58% away from the 200-day moving average. The […]
There is little time left for TRACON Pharmaceuticals Inc (TCON) to reach its 1-year target estimate. How soon will it surpass it?
TRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded 43.94% higher at $0.23 on Wall Street last session. In accordance with the data, 3 analysts cover TRACON Pharmaceuticals Inc (NASDAQ:TCON). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $7.00 and a low of $1.00, […]
How should investors evaluate TRACON Pharmaceuticals Inc. (NASDAQ:TCON)?
Stocks of TRACON Pharmaceuticals Inc. (NASDAQ:TCON) traded higher last session on Wall Street, up 14.06% to $0.37. According to the data, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) has 4 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $12.00 and […]
